Contemp Oncol (Pozn). 2016; 20(2): 119–123. 
Published online 2016 Jun 14.   doi:  10.5114/wo.2016.60065
PMCID: PMC4925730
Department of Clinical Oncology, University Hospital in Krakow, Krakow, Poland
Corresponding author.
Address for correspondence: Mirosława Puskulluoglu, Department of Clinical Oncology, University Hospital in Krakow, Śniadeckich 10, 31-501 Krakow, Poland. e-mail: lp.pw@llocrim
Abstract
Abstract
Acupuncture
 is a complementary and alternative medical treatment (CAM) which is 
increasingly used in the care of cancer patients. Traditionally derived 
from Chinese medicine, nowadays it is becoming a part of evidence-based 
oncology. The use of acupuncture in these patients has been recommended 
by the American Cancer Society (ACS) for the treatment of side effects 
associated with conventional cancer therapy and cancer-related ailments.
 A growing body of evidence supports the use of acupuncture in the 
treatment of cancer-induced pain and chemotherapy-related nausea and 
vomiting. Also other indications, such as xerostomia, fatigue, hot 
flashes, anxiety and peripheral neuropathy, are being constantly 
evaluated. This article summarizes the most important discoveries 
related to the possible usefulness of this method in contemporary 
oncology. Emphasis is placed on the results of randomized controlled 
trials with an adequate level of evidence. However, explanation of the 
mechanisms responsible for these effects requires confirmation in 
further studies with an adequate level of evidence. In future, 
acupuncture may become an interesting and valuable addition to 
conventional medicine.
Keywords: acupuncture, cancer, complementary and alternative treatment, side effects, supportive treatment
Introduction
Complementary and alternative medical treatment (CAM) has gained significant interest in recent years [1].
 Although the list of CAM has changed over the years, the Office of 
Alternative Medicine (established at the National Institutes of Health 
[NIH] in the USA) nowadays recognizes five major categories [2].
 Acupuncture, belonging to the Manipulative Therapies category, due to 
its low cost, safety (considering all possible contraindications) and 
the minimal number of side effects is gaining popularity among patients [3].
 Acupuncture has repeatedly been reported to be useful in oncological 
practice in alleviating side effects of anti-tumor treatment. Numerous 
clinical trials of acupuncture indicate its potential role in fighting 
the following ailments: nausea and chemotherapy-induced vomiting, pain, 
xerostomia, vasomotor symptoms, neutropenia, fatigue, anxiety, insomnia,
 lymphoedema after mastectomy, and peripheral neuropathy [4–16].
 A sudden increase in the number of studies on acupuncture in oncology 
was first noted in 1997, when at the NIH conference a consensus was 
reached on the use of acupuncture, which was then acknowledged as a 
useful medical procedure [17]. This article reviews the literature concerning the referred studies.
What is acupuncture?
Acupuncture
 is a method of treatment that has its origins in Traditional Chinese 
Medicine and is based on over 4,000 years of empirical evidence. The 
technique involves the insertion of thin needles into specific locations
 (energy points) on the patient's body along energy pathways or 
meridians. According to Chinese philosophy, the hypothetical substance 
Qi (vital energy) flows in the human body along the meridians, and 
blockage of Qi leads to a particular ailment [18].
 There are 12 main and 8 extra meridians. All the main meridians consist
 of internal channels connected with the 12 body organs and the external
 channels spreading symmetrically on the skin surface. The literature 
describes around 360 energy points located on the external parts of the 
meridians. Acupuncture is considered to cure diseases by stimulating 
particular acupoints and removing blockage of Qi [19]. Figures 1–3 present acupuncture meridian pathways.
Although
 acupuncture has been studied extensively in both animal and human 
models, little is known about its mechanisms that could explain 
acupuncture's therapeutic qualities. Table 1
 shows suggested mechanisms of acupuncture. This treatment method has 
been the focus of increased interest, which has resulted in a growing 
number of studies.
Acupuncture as supportive treatment
Chemotherapy
 agents are considered to be medications with the most severe side 
effects, which in many cases may force the patient to abandon therapy. 
Because of that, proper alleviation of side effects is most crucial. 
Acupuncture should not be seen as a replacement for modern medicines, 
but rather an adjunct with a low level of procedure-related 
complications that may enhance efficacy and in some cases allow the 
dosage of other drugs to be reduced. Acupuncture as part of supportive 
treatment in oncology has been tested for numerous indications. The 
strongest evidence from a randomized controlled trial (RCT) with low 
risk of bias supports the use of acupuncture for control of nausea and 
vomiting related to chemotherapy [25].
 This indication seems to be very important, as the high emetogenicity 
of many cytostatic agents is hard to control even with three-drug 
therapy [26].
 Despite many RCTs on treatment of other chemotherapy-induced side 
effects, the level of evidence is not yet satisfactory, but considering 
its relative safety, acupuncture may be useful in everyday practice. 
Descriptions of these clinical trials on the effectiveness of 
acupuncture in minimizing cancer treatment-related side effects are 
summarized in Table 2.
Level of evidence issue
A
 recently published systemic review stated that other indications, such 
as pain, xerostomia, vasomotor symptoms, fatigue, mood disorders, and 
insomnia, were not evaluated in RCTs with an appropriate level of 
evidence [44].
 One of the major problems with the reviewed studies is their poor 
methodological quality, mostly difficulty with blinding and a low number
 of subjects. Also the optimal design of such studies (acupuncture vs 
placebo, acupuncture vs sham acupuncture) has not been established yet [45]. In spite of satisfactory results in most of these studies, further research on a larger group of patients is necessary.
Summary
In
 an oncological setting, acupuncture is still being constantly reviewed.
 Nevertheless, the present available evidence suggests that acupuncture 
may become a safe, low-cost and efficient form of complementary therapy 
in modern oncology. The potential role of acupuncture has been found in 
alleviation of various symptoms, but the data from the majority of 
clinical studies on acupuncture are heterogeneous. The incomplete 
description of procedural methodology and insufficient patient groups 
limit their value. Thus, further research on a larger scale on the 
potential use of acupuncture in contemporary oncology is required. It 
should be emphasized that alternative medicine may become the source of a
 number of interesting concepts worth examining and testing in research 
and clinical settings.
The authors declare no conflict of interest.
References
1. Molassiotis
 A, Fernadez-Ortega P, Pud D, et al.  Use of complementary and 
alternative medicine in cancer patients: a European survey. Ann. Oncol. 2005;16:655–63.  [PubMed]
2. Hök
 J, Tishelman C, Ploner A, et al.  Mapping patterns of complementary and
 alternative medicine use in cancer: an explorative cross-sectional 
study of individuals with reported positive “exceptional” experiences. BMC Complement Altern Med. 2008;8:48. [PMC free article]  [PubMed]
3. White A. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med. 2004;22:122–33.  [PubMed]
4. Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies. Auton Neurosci. 2006;129:107–17.  [PubMed]
5. Yang
 Y, Zhang Y, Jing N, et al.  Electroacupuncture at Zusanli (ST 36) for 
treatment of nausea and vomiting caused by the chemotherapy of the 
malignant tumor: a multicentral randomized controlled trial. Zhongguo Zhen Jiu. 2009;29:955–8.  [PubMed]
6. Gottschling
 S, Reindl TK, Meyer S, et al.  Acupuncture to alleviate 
chemotherapy-induced nausea and vomiting in pediatric oncology – a 
randomized multicenter crossover pilot trial. Klin Padiatr. 2008;220:365–70.  [PubMed]
7. Dang W, Yang J. Clinical study on acupuncture treatment of stomach carcinoma pain. J Tradit Chin Med. 1998;18:31–8.  [PubMed]
8. Alimi
 D, Rubino C, Pichard-Léandri E, et al.  Analgesic effect of auricular 
acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003;21:4120–6.  [PubMed]
9. Braga
 FP, Lemos Junior CA, Alves FA, Migliari DA. Acupuncture for the 
prevention of radiation-induced xerostomia in patients with head and 
neck cancer. Braz Oral Res. 2011;25:180–5.  [PubMed]
10. Liljegren
 A, Gunnarsson P, Landgren B-M, et al.  Reducing vasomotor symptoms with
 acupuncture in breast cancer patients treated with adjuvant tamoxifen: a
 randomized controlled trial. Breast Cancer Res. Treat. 2012;135:791–8.  [PubMed]
11. Lu
 W, Matulonis UA, Doherty-Gilman A, et al.  Acupuncture for 
chemotherapy-induced neutropenia in patients with gynecologic 
malignancies: a pilot randomized, sham-controlled clinical trial. J Altern Complement Med. 2009;15:745–53. [PMC free article]  [PubMed]
12. Molassiotis
 A, Sylt P, Diggins H. The management of cancer-related fatigue after 
chemotherapy with acupuncture and acupressure: a randomised controlled 
trial. Complement Ther Med. 2007;15:228–37.  [PubMed]
13. Eich
 H, Agelink MW, Lehmann E, et al.  Acupuncture in patients with minor 
depressive episodes and generalized anxiety. Results of an experimental 
study. Fortschr Neurol Psychiatr. 2000;68:137–44.  [PubMed]
14. Frisk
 J, Källström A-C, Wall N, et al.  Acupuncture improves health-related 
quality-of-life (HRQoL) and sleep in women with breast cancer and hot 
flushes. Support Care Cancer. 2012;20:715–24.  [PubMed]
15. Cassileth
 BR, Van Zee KJ, Chan Y, et al.  A safety and efficacy pilot study of 
acupuncture for the treatment of chronic lymphoedema. Acupunct Med. 2011;29:170–2. [PMC free article]  [PubMed]
16. Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med. 2011;29:230–3.  [PubMed]
17. NIH. Consensus Conference. Acupuncture. JAMA. 1998;280:1518–24.  [PubMed]
18. Zhao
 XL, Han JX. The connotation of the Quantum Traditional Chinese Medicine
 and the exploration of its experimental technology system for 
diagnosis. Drug Discov Ther. 2013;7:225–32.  [PubMed]
19. Perlow BW. Acupuncture: its theory and use in general practice. Proc R Soc Med. 1973;66:426–8. [PMC free article]  [PubMed]
20. Chae
 Y, Hong M-S, Kim G-H, et al.  Protein array analysis of cytokine levels
 on the action of acupuncture in carrageenan-induced inflammation. Neurol Res. 2007;29:S55–8.  [PubMed]
21. Su
 T-F, Zhao Y-Q, Zhang L-H, et al.  Electroacupuncture reduces the 
expression of proinflammatory cytokines in inflamed skin tissues through
 activation of cannabinoid CB2 receptors. Eur J Pain. 2012;16:624–35.  [PubMed]
22. Anderson
 B, Nielsen A, McKee D, et al.  Acupuncture and heart rate variability: a
 systems level approach to understanding mechanism. Explore (NY) 2012;8:99–106.  [PubMed]
23. Moldenhauer
 S, Burgauner M, Hellweg R, et al.  Mobilization of CD133(+)CD34(-) 
cells in healthy individuals following whole-body acupuncture for spinal
 cord injuries. J Neurosci Res. 2010;88:1645–50.  [PubMed]
24. Yang
 Z, Chen P, Yu H, et al.  Research advances in treatment of cerebral 
ischemic injury by acupuncture of conception and governor vessels to 
promote nerve regeneration. Zhong Xi Yi Jie He Xue Bao. 2012;10:19–24.  [PubMed]
25. Shen
 J, Wenger N, Glaspy J, et al.  Electroacupuncture for control of 
myeloablative chemotherapy-induced emesis: A randomized controlled 
trial. JAMA. 2000;284:2755–61.  [PubMed]
26. Gralla
 RJ, de Wit R, Herrstedt J, et al.  Antiemetic efficacy of the 
neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a 
corticosteroid in patients receiving anthracyclines or cyclophosphamide 
in addition to high-dose cisplatin: analysis of combined data from two 
Phase III randomized clinical trials. Cancer. 2005;104:864–8.  [PubMed]
27. Han J-S. Acupuncture and endorphins. Neurosci Lett. 2004;361:258–61.  [PubMed]
28. Han
 JS, Xie GX, Zhou ZF, et al.  Acupuncture mechanisms in rabbits studied 
with microinjection of antibodies against beta-endorphin, enkephalin and
 substance P. Neuropharmacology. 1984;23:1–5.  [PubMed]
29. Wu GC, Zhu J, Cao X. Involvement of opioid peptides of the preoptic area during electroacupuncture analgesia. Acupunct Electrother Res. 1995;20:1–6.  [PubMed]
30. Hsieh
 JC, Tu CH, Chen FP, et al.  Activation of the hypothalamus 
characterizes the acupuncture stimulation at the analgesic point in 
human: a positron emission tomography study. Neurosci Lett. 2001;307:105–8.  [PubMed]
31. Choi
 TY, Lee MS, Kim TH, et al.  Acupuncture for the treatment of cancer 
pain: a systematic review of randomised clinical trials. Support Care Cancer. 2012;20:1147–58.  [PubMed]
32. Zhao
 X, Wang H, Tian K, et al.  Review on mechanisms of 
acupuncture-moxibustion against leukopenia due to chemotherapy induced 
myeloid inhibition. Acupuncture Research. 2003;1:70–3.
33. Zhao
 X, Huang X, Wang H, et al.  Study on the Mechanism of Acupuncture in 
Fighting Chemotherapeutic Marrow Depression and Enhancing WBC. Shanghai Journal of Acupuncture and Moxibustion. 2003;1:29–33.
34. Lu
 W, Hu D, Dean-Clower E, et al.  Acupuncture for chemotherapy-induced 
leukopenia: exploratory meta-analysis of randomized controlled trials. J Soc Integr Oncol. 2007;5:1–10.  [PubMed]
35. Crew
 KD, Capodice JL, Greenlee H, et al.  Randomized, blinded, 
sham-controlled trial of acupuncture for the management of aromatase 
inhibitor-associated joint symptoms in women with early-stage breast 
cancer. J Clin Oncol. 2010;28:1154–60.  [PubMed]
36. Deng
 G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance 
imaging (fMRI) changes and saliva production associated with acupuncture
 at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008;8:37. [PMC free article]  [PubMed]
37. Dawidson
 I, Angmar-Mânsson B, Blom M, et al.  Sensory stimulation (acupuncture) 
increases the release of calcitonin gene-related peptide in the saliva 
of xerostomia sufferers. Neuropeptides. 1999;33:244–50.  [PubMed]
38. Spetz
 Holm A-CE, Frisk J, Hammar ML. Acupuncture as treatment of hot flashes 
and the possible role of calcitonin gene-related Peptide. Evid Based Complement Alternat Med. 2012;2012:579321. [PMC free article]  [PubMed]
39. Bokmand
 S, Flyger H. Acupuncture relieves menopausal discomfort in breast 
cancer patients: a prospective, double blinded, randomized study. Breast. 2013;22:320–3.  [PubMed]
40. Park
 HJ, Chae Y, Jang J, et al.  The effect of acupuncture on anxiety and 
neuropeptide Y expression in the basolateral amygdala of maternally 
separated rats. Neurosci Lett. 2005;377:179–84.  [PubMed]
41. Chae
 Y, Yeom M, Han JH, et al.  Effect of acupuncture on anxiety-like 
behavior during nicotine withdrawal and relevant mechanisms. Neurosci Lett. 2008;430:98–102.  [PubMed]
42. Lu
 W, Posner MR, Wayne P, et al.  Acupuncture for dysphagia after 
chemoradiation therapy in head and neck cancer: a case series report. Integr Cancer Ther. 2010;9:284–90. [PMC free article]  [PubMed]
43. Ge AX, Ryan ME, Giaccone G, et al.  Acupuncture treatment for persistent hiccups in patients with cancer. J Altern Complement Med. 2010;16:811–6. [PMC free article]  [PubMed]
44. Garcia MK, McQuade J, Haddad R, et al.  Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31:952–60. [PMC free article]  [PubMed]
45. White
 AR, Filshie J, Cummings TM, International Acupuncture Research Forum  
Clinical trials of acupuncture: consensus recommendations for optimal 
treatment, sham controls and blinding. Complement Ther Med. 2001;9:237–45.  [PubMed]
Articles from Contemporary Oncology are provided here courtesy of Termedia Publishing


